ABOS - Acumen Pharmaceuticals Inc. (ABOS) CEO Daniel O'Connell On Q4 2021 Results - Earnings Call Transcript
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2021 Earnings Conference Call March 28, 2022 4:30 AM ET Company Participants John Woolford - IR, Westwicke Daniel O'Connell - President & CEO Eric Siemers - Chief Medical Officer Matt Zuga - CFO & Chief Business Officer Conference Call Participants Alex Park - Stifel Jason Zemansky - Bank of America Judah Frommer - Credit Suisse Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:07 Thank you for standing by, and welcome to the Acumen Pharmaceuticals, Fourth Quarter and Full-Year 2021 Update Call. At this time, all participants are in a listen-only mode. There'll be a presentation followed by a question-and-answer session. [Operator Instructions]
For further details see:
Acumen Pharmaceuticals, Inc. (ABOS) CEO Daniel O'Connell On Q4 2021 Results - Earnings Call Transcript